Definitive Contract 75F40119C10086
Award Date 9/10/19
Potential Completion Date 12/30/22
Potential Value $1.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...
- This federal contract was awarded to Duke University by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to support the development and deployment of COVID-19 vaccines under Operation Warp Speed. The $281,376.08 definitive cost-no-fee contract, awarded on September 17, 2021, does not have a set-aside designation. The contract supports research and development activities to advance regulatory science and innovation, which aligns with Duke University's expertise...
- The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
- This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency, to Duke University as the prime contractor. The $236,068.40 fixed-price cost contract is for biomedical research and exploratory studies, with a performance period ending on June 30, 2013. Duke University is a private, non-profit educational institution that has extensive experience delivering a wide range of research and development services to federal agencies through both...
- The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
- This is a $1,206,589.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is for research and development to quantify patient priorities for clinical evidence on the impact of osseointegrated limb prostheses. This award was made under the FDA's Broad Agency Announcement for regulatory science and innovation research, with no set-aside designation. Duke University has previously received...
- This federal contract award, valued at $400,734.35, was made by the Defense Health Agency to Duke University, a private non-profit university, for a new research contract. The award does not have a set-aside designation. The contract is a definitive contract of the cost-no-fee pricing type, with a performance period ending on December 29, 2018. Duke University's Office of Research Administration Division is the prime contractor. The award indicates that Duke University has been awarded...
- This is a definitive contract awarded by the Department of the Navy Naval Sea Systems Command to Duke University's Office of Research Administration Division, a private non-profit university, on January 25, 2019. The contract is for a research study with a potential value of $299,112.00 and a completion date of October 30, 2021. The contract is a cost-no-fee type, and there was no set-aside designation indicated. Duke University has a history of providing a variety of goods and services to the...
- This is a definitive federal contract awarded by the U.S. government to Duke University's Office of Research Administration Division as the prime contractor. The $3,252,484.82 contract is for biomedical research and exploratory development services, with no set-aside designation used. The contract appears to be part of a larger indefinite delivery/indefinite quantity (IDIQ) vehicle awarded to Duke by the Centers for Disease Control and Prevention (CDC) to provide clinical research and...